Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Velazquez

Showing results (71-80 of 357) with videos related to

Pageof 36
Sort By:
ESC Heart Failure|November 21, 2017
Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalizationJonathan Buggey, Fawaz Alenezi, Hyun Ju Yoon, et al.
The New England Journal of Medicine|November 13, 2018
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart FailureEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Journal of Cardiac Failure|July 3, 2018
Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical CohortNwora Lance Okeke, Fawaz Alenezi, Gerald S Bloomfield, et al.
American Heart Journal|June 19, 2018
The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patientsDaniel J Friedman, Marat Fudim, Robert Overton, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HFGuangyu Tong, Changjun Li, Fan Li, et al.
The American Journal of Cardiology|July 8, 2008
Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapyMark A Trimble, Salvador Borges-Neto, Eric J Velazquez, et al.
Journal of the American College of Cardiology|April 9, 2013
Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fractionMads Ersbøll, Nana Valeur, Ulrik Madvig Mogensen, et al.
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
The American Journal of Cardiology|February 4, 2017
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial FibrillationJoanne Wyrembak, Kristen B Campbell, Benjamin A Steinberg, et al.
Pageof 36

Showing results (71-80 of 357) with videos related to

Sort By:
Pageof 36
ESC Heart Failure|November 21, 2017
Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalizationJonathan Buggey, Fawaz Alenezi, Hyun Ju Yoon, et al.
The New England Journal of Medicine|November 13, 2018
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart FailureEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Journal of Cardiac Failure|July 3, 2018
Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical CohortNwora Lance Okeke, Fawaz Alenezi, Gerald S Bloomfield, et al.
American Heart Journal|June 19, 2018
The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patientsDaniel J Friedman, Marat Fudim, Robert Overton, et al.
Circulation. Heart Failure|February 3, 2021
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF TrialDavid D Berg, Marc D Samsky, Eric J Velazquez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HFGuangyu Tong, Changjun Li, Fan Li, et al.
The American Journal of Cardiology|July 8, 2008
Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapyMark A Trimble, Salvador Borges-Neto, Eric J Velazquez, et al.
Journal of the American College of Cardiology|April 9, 2013
Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fractionMads Ersbøll, Nana Valeur, Ulrik Madvig Mogensen, et al.
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
The American Journal of Cardiology|February 4, 2017
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial FibrillationJoanne Wyrembak, Kristen B Campbell, Benjamin A Steinberg, et al.
Pageof 36